Clinical Trials on 边缘区B细胞淋巴瘤 in China
总计1104个结果
-
Hutchison Medipharma Limited未知
-
BeiGene招聘中
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University Cancer...招聘中年龄范围≥16岁,性别不限 | 组织病理学证实弥漫性大 B 细胞淋巴瘤或高级别 B 细胞淋巴瘤 | 先前接受过 DLBCL 或 HGBL 的一线化疗,四个周期未能达到 CR,或复发 | 根据 2014 年霍奇金和非霍奇金淋巴瘤卢加诺标准至少有一个阳性病变 | ECOG 身体状况评分为 0-3 | 研究人员判断预期寿命至少为三个月 | 了解并自愿签署书面知情同意书中国
-
Antengene Corporation主动,不招人
-
Novartis Pharmaceuticals主动,不招人
-
Hoffmann-La Roche完全的
-
Antengene (Hangzhou) Biologics Co., Ltd.招聘中
-
Incyte Biosciences Japan GK招聘中
-
Cothera Bioscience, Inc招聘中淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴系统疾病 | 伯基特淋巴瘤 | 高级别 B 细胞淋巴瘤 | C-MYC/BCL6 双重打击高级别 B 细胞淋巴瘤 | C-MYC/BCL2 双重打击高级别 B 细胞淋巴瘤 | 淋巴瘤,高级 | C-Myc基因重排大韩民国, 中国
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Hebei Senlang Biotechnology Inc., Ltd.Cangzhou People's Hospital招聘中
-
Kecellitics Biotech Company LtdHebei Yanda Ludaopei Hospital尚未招聘
-
First Affiliated Hospital of Zhejiang UniversityHangzhou HeZheng Pharmaceutical Co., Ltd未知
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang University完全的
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.终止
-
He HuangGracell Biotechnology Ltd.尚未招聘
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.招聘中
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; Suzhou Hongci Hematology Hospital,...招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Shenzhen Second People's HospitalShenzhen Institute for Innovation and Translational Medicine未知
-
Qingdao Central HospitalYake Biotechnology Ltd.未知
-
Tianjin Medical University Cancer Institute and...Cellular Biomedicine Group Ltd.主动,不招人
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Rongu Biotechnology Co., Ltd.招聘中
-
AbbVie完全的癌症 | 慢性淋巴细胞白血病 (CLL) | 小淋巴细胞白血病 (SLL)日本
-
Shenzhen Institute for Innovation and Translational...Dongguan People's Hospital完全的
-
Shanghai Tongji Hospital, Tongji University School...Cellular Biomedicine Group Ltd.主动,不招人
-
Ruijin Hospital未知淋巴瘤,大 B 细胞,弥漫性 | III 期滤泡性淋巴瘤中国
-
Peking UniversityShanghai Mingju Biotechnology Co., Ltd.未知
-
Beijing InnoCare Pharma Tech Co., Ltd.招聘中
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province Cancer Hospital; Sun Yat-sen University 和其他合作者招聘中
-
Zhao WeiliShanghai Mingju Biotechnology Co., Ltd.未知
-
National Cancer Institute (NCI)主动,不招人弥漫性大 B 细胞淋巴瘤 | 具有 MYC 和 BCL2 或 BCL6 重排的高级别 B 细胞淋巴瘤 | 弥漫性大 B 细胞淋巴瘤,未另行说明 | 双表达淋巴瘤 | EBV 阳性弥漫性大 B 细胞淋巴瘤,未另行说明 | 高级 B 细胞淋巴瘤,未另行说明 | 存在 MYC 和 BCL2 蛋白双重表达的肿瘤细胞 | 将惰性 B 细胞非霍奇金淋巴瘤转化为弥漫性大 B 细胞淋巴瘤美国